Institutions / Sio Capital Management, LLC / Holdings
Back to Sio Capital Management, LLC

Sio Capital Management, LLC

All holdings · as of Dec 31, 2025

65 positions

CompanyClassValueShares% of portfolio
Celcuity Inc.CELCCommon Stock$47.58M477,0677.9%
Cigna Group—$47.40M172,2037.9%
SANOFI—$47.09M971,6867.8%
Maximus Inc—$43.19M500,3047.2%
Zimmer Biomet Holdings Inc—$34.68M385,6425.7%
Kenvue Inc.—$25.28M1,465,4424.2%
Organon & Co.—$24.53M3,421,7654.1%
ICON plc—$23.18M127,2023.8%
Waystar Holding Corp.—$20.10M613,7253.3%
LivaNova PLC—$19.84M322,3823.3%
Dianthus Therapeutics, Inc.—$19.55M474,5033.2%
Biohaven Ltd.—$14.05M1,244,7642.3%
Structure Therapeutics Inc.GPCRADR$14.01M201,5002.3%
BioMarin Pharmaceutical Inc—$13.83M232,6882.3%
Tyra Biosciences, Inc.—$13.83M526,0022.3%
BrightSpring Health Services, Inc.—$11.53M308,0101.9%
Centene Corp—$11.29M274,3501.9%
CHARLES RIVER LABS INTL INC—$10.97M54,9851.8%
TELEFLEX INC—$10.60M86,8761.8%
Anteris Technologies Global Corp.—$9.35M1,874,6411.6%
Protara Therapeutics, Inc.—$9.14M1,715,3941.5%
CROSS COUNTRY HEALTHCARE INC—$8.66M1,068,8211.4%
Haemonetics Corporation—$7.42M92,6311.2%
ANI PHARMACEUTICALS INC—$6.89M87,2721.1%
Aquestive Therapeutics, Inc.AQSTCommon Stock$6.42M993,0951.1%
BRIGHT MINDS BIOSCIENCES INC.—$6.39M81,8831.1%
Edgewise Therapeutics, Inc.—$5.89M237,4811.0%
ABIVAX SA—$5.82M43,1241.0%
Crinetics Pharmaceuticals, Inc.—$5.81M124,8411.0%
Rapport Therapeutics, Inc.RAPPCommon Stock$5.62M185,2650.9%
Cencora Inc—$5.37M15,9000.9%
MCKESSON CORP—$5.25M6,4000.9%
Disc Medicine, Inc.IRONCommon Stock$4.57M57,5860.8%
PROQR THERAPEUTICS N V—$4.37M2,164,1810.7%
Fulcrum Therapeutics, Inc.—$4.32M382,0000.7%
Savara IncSVRACommon Stock$3.70M613,8880.6%
Oruka Therapeutics, Inc.—$3.58M118,1260.6%
Ventyx Biosciences, Inc.—$3.50M387,7510.6%
PMV Pharmaceuticals, Inc.PMVPCommon Stock$3.30M2,636,5480.5%
SHOULDER INNOVATIONS, INC.SICommon Stock$3.26M227,9710.5%
Aligos Therapeutics, Inc.—$3.13M335,9370.5%
Vir Biotechnology, Inc.—$2.88M478,3430.5%
Alkermes plc.—$2.67M95,3530.4%
IDEAYA BIOSCIENCES, INC.—$2.62M75,7300.4%
Kymera Therapeutics, Inc.—$2.51M32,2350.4%
Ovid Therapeutics Inc.—$2.33M1,427,4950.4%
Context Therapeutics Inc.—$1.97M1,341,6360.3%
Hyperfine, Inc.HYPRCommon Stock$1.96M2,000,0000.3%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$1.64M130,6280.3%
iBio, Inc.IBIOCommon Stock$1.43M740,0000.2%
← PrevPage 1 of 2Next →